PPD Strengthens Drug Development Expertise with New Therapeutic Area Professionals

Pharmaceutical Product Development, LLC (PPD) has enhanced its global product development services, adding significant expertise in multiple therapeutic areas, including neuroscience, hematology/oncology, rare diseases and pediatrics.

PPD’s appointment of Amy Chappell, M.D., and Alberto Lledó, M.D., Ph.D., in neuroscience; Timothy Miller, M.D., in rare diseases and pediatrics; and Konstantin Stoitchkov, M.D., Ph.D., in hematology/oncology strengthens PPD’s team of therapeutic area professionals with extensive product development and commercialization experience, who help clients address critical drug development challenges.

“As the drug development process continues to become more complex, our clients are looking to PPD to provide medical and scientific expertise and strategic direction that extend far beyond traditional clinical trial implementation,” said Rob Dow, M.B.CH.B., F.R.C.P.E., F.F.P.M., who, as chief medical officer, oversees PPD’s therapeutic areas. “These experts have held senior leadership roles in various capacities in the life sciences industry, providing them with a wide range of experience that offers significant strategic value to our clients.”